|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Mirtazapine (Remeron), Serum or Plasma
Test Code30348N
Preferred Specimen
Red Top

Minimum Volume
1.2 mL
Other Acceptable Specimens
Plasma collected in: EDTA (lavender-top) or sodium fluoride (gray-top) tube
Instructions
Promptly centrifuge and separate serum or plasma into a transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 14 days
Refrigerated: 14 days
Frozen: 14 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tube (SST) or PST
Methodology
Gas Chromatography (GC)
FDA Status
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Setup Schedule
Set up: As needed; Report available: 4 days
Reference Range
See Laboratory Report
Clinical Significance
Therapeutic drug monitoring.

